Abstract

ObjectivesActivated protein C (APC) has a protective efficacy against ischemia-reperfusion (I/R) injury in several organs. The objective of this study was to investigate effect of APC in myocardium with possible mechanism.MethodsWe used regional and global myocardial I/R injury models of rats. They consisted of I/R injuries (1) by ligation of left coronary artery, or (2) using Langendorff apparatus. Langendorff was used to focus the mechanism of APC excluding coagulation cascade in a working heart. Each experiment had an APC group (n = 10) and a control group with normal saline (n = 10). Injections of these solutions into rats were performed 30 minutes before the planned-I/R injury. Cardiac performance after the procedure was evaluated by echocardiography or indices with Langendorff apparatus. Coronary flow (CF) was measured in the global I/R injury model. Western blotting was performed to detect the change of AKT1 signal in myocardium after global I/R injury.ResultsLV function improved significantly in the APC group: %EF at 2 weeks after procedure, 70.8%±4.5% vs. 56.5%±0.7%; APC vs. control; p<0.01. Percent LV development pressure (LVDP) also improved in the APC group significantly, 88.8%±45.3% vs. 28.1%±15.4%; APC vs. control; p<0.01. In APC group, %CF improved significantly, 88.5%±15.8% vs. 65.0%±13.4%; APC vs. control; p<0.01. It was enhanced significantly when acetylcholine was administered; % CF: 103.5%±9.9% vs. 87.0%±12.1%; APC vs. control; p<0.05. Western blotting revealed that APC significantly induced activation of phosphorylated AKT1 in myocardium (p<0.05).ConclusionsAPC has a novel effect to protect myocardium and cardiac performance against I/R injury through improvement of endothelial function and activation of AKT1.

Highlights

  • Standard treatment for ischemic heart disease is revascularization of coronary artery

  • We considered that left coronary artery (LCA) ligation model supported clinical situation that was not able to be experimented by Langendorff model alone

  • At 1 week after the procedure of I/R injury, %Ejection fraction (EF) and %fractional shortening (FS) were higher in Activated protein C (APC) group than controls (%EF: APC group, 74.6%610.9% vs. controls, 58.8%66.9%; p = 0.05; %FS: APC group, 39.7%610.5% vs. controls, 27.6%64.5%; p = 0.08)

Read more

Summary

Introduction

Standard treatment for ischemic heart disease is revascularization of coronary artery. It is performed by percutaneous intervention or surgical procedure, using cardiopulmonary bypass (CPB). Revascularization induces ischemia-reperfusion (I/R) injury in the regional myocardium. CPB and cardiac arrest during cardiac surgery can be a cause of global myocardial I/R injury. I/R injury relate to coagulation cascade in abnormal condition, inflammation, endothelial dysfunction, apoptosis and necrosis. To prevent organs from I/R injury, many effective drugs have been discovered by regulating these mechanisms [1,2]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call